Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

MED holding history

Medifast Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MED overviewAll 13F holders of MEDFull Q2 2026 holdings

Shares (Q2 2026)
92,345
Value
$979.8K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of MED by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202692,345$979.8K<0.1%−68,219−42.5%ReducedHolders
Q1 2026160,564$1.64M<0.1%−58,554−26.7%ReducedHolders
Q4 2025219,118$2.34M<0.1%−44,530−16.9%ReducedHolders
Q3 2025263,648$3.60M<0.1%−57,581−17.9%ReducedHolders
Q2 2025321,229$4.51M<0.1%−12,217−3.7%ReducedHolders
Q1 2025333,446$4.49M<0.1%+44,663+15.5%AddedHolders
Q4 2024288,783$5.09M<0.1%+80,000+38.3%AddedHolders
Q3 2024208,783$4.00M<0.1%−129,025−38.2%ReducedHolders
Q2 2024337,808$7.37M<0.1%+245,923+267.6%AddedHolders
Q1 202491,885$3.52M<0.1%+40,647+79.3%AddedHolders
Q4 202351,238$3.44M<0.1%+389+0.8%AddedHolders
Q3 202350,849$3.81M<0.1%−28,792−36.2%ReducedHolders
Q2 202379,641$7.34M<0.1%−6,530−7.6%ReducedHolders
Q1 202386,171$8.93M<0.1%+70,108+436.5%AddedHolders
Q4 202216,063$1.85M<0.1%+13,160+453.3%AddedHolders
Q3 20222,903$315.0K<0.1%+1,679+137.2%AddedHolders
Q2 20221,224$221.0K<0.1%−757−38.2%ReducedHolders
Q1 20221,981$338.0K<0.1%−9,493−82.7%ReducedHolders
Q4 202111,474$2.40M<0.1%+11,474NewHolders
Q2 20210$00.0%−2,397−100.0%Sold outHolders
Q1 20212,397$508.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.